T-CELL PROTECT 60's

     T CELL PROTECT- supports your immune system

T-CELL PROTECT is a groundbreaking proprietary blend of plant extracts that helps support healthy immune function.

T-CELL PROTECT is a potent botanical, delayed release, bioavailable 3CL protease inhibitor. Description Benefits:

The healthy way to support your immune system.

High in antioxidants and may fight inflammation and boost skin health.

Plant based and vegan friendly.

Scientifically studied.

Traceable ingredients.

Made in the USA at a cGMP FDA Regulated Facility.

Intention:

Supports and maintenance of healthy immune function.

Suggested Use: Adults take 3 capsules 4 times daily or as directed by a physician.

For Children under 18, consult your physician.

Store in a cool, dry place.

Caution:

If you are pregnant, nursing, or may become pregnant, have a medical condition or are taking any medications consult with your doctor before use.

Size: 1 bottle includes 60 Individual Vegetable Capsules.

Ingredients:

Lithospermum Erythrochizon Extract (from Gromwell Root), Lecithin, Powdered Cellulose, Enteric HPMC Vegetable Capsule (Delayed Response Formulation), Silicon dioxide (Natural Thickening agent), Magnesium Stearate (Natural Emulsifier). Manufactured on equipment that may process products containing soy, dairy, or nuts.

Meet the Maker:

Made under the careful stewardship of Todos Medical USA.

DISCLAIMER:

These statements have not been evaluated by the Food and Drug Administration.

This product is not intended to diagnose, treat, cure, or prevent any disease.

If pregnant, consult a physician before use.

CAUTION:

If you are pregnant, nursing, taking any medications or have any medical condition, consult a healthcare professional before use. KEEP OUT OF REACH OF CHILDREN.

Lithospermum_erythrorhizon-1

Lithospermum Erythrorhizon Shikonin is the active ingredient of Gromwell Root and is one of the most famous active compounds of traditional use.

Extensive studies conducted over the last 30 years have shown that Shikonin and its derivatives have been shown to be very important active ingredient. Shikonin has been extensively researched and the following conclusions have been derived:

Shikonin-containing extracts exhibit anti-inflammatory, anti-cancer and immunoregulatory properties in both the in vitro and the in vivo model systems.

Shikonin has been shown to be extremely safe in a variety of preclinical studies having a strong safety history as common dietary supplements for human use.

Shikonin is known for its anti-viral, anti-microbial and anti-cancer properties, while clinical trials on their anti-cancer properties continue to be performed. In fact, there is a patent established in 2005 on the anti-viral properties of Shikonin.

A test performed during the SARS epidemic showed that Shikonin reduced the course of SARS from 11 to 6 days and that it has anti-viral properties.

Dr. Dorit Arad's team at eXegenics in 2001, found that Shikonin has molecular activity against several viruses, particularly the 3C-target viral protease enzyme, and it was detected as the most active compound among the 300,000 compounds researched in this study.

Gromwell Root, which contains 30% Shikonin, is regulated in Israel as a safe herbal supplement with a therapeutic index> 100 for concentrations up to 20mg per Kg.

More about Shikonin’s anti-viral properties:

When a virus infects the body's cells, it begins to use human cells and their various mechanisms in order to be able to reproduce and create new viruses. The process of activating cells to produce viral proteins and make more copies of the virus is a key point in the pathogenicity of the virus and its ability to infect new cells and survive.

Initially, the infected cell forms a series of viral proteins which are mostly non-functional. Some enzymes, called proteases, break down the precursor molecules of proteins in specific areas for the productive functional molecules that exist for viruses, survival, reproduction and the growth of new cells. 

              ABOUT THE PRODUCT

T-Cell Protect is a proprietary blend of plant extracts and advanced 3CL Protease inhibitors that supports and stabilizes immune function. The supplement starves harmful binding viruses, mitigating their ability to multiply. The product was developed by Dr. Dorit Arad, a D.C. in physical organic chemistry from the Technion – Israel Institute of Technology, that has more than 25 years of experience in the life science industry as an international researcher, executive and entrepreneur.

Dr. Dorit Arad is an interdisciplinary scientist with expertise in several fields:

Academic experience as a chemist from the Technion, Computer assisted Drug Design from UCSF and Drug Design and Biotechnology as a professor in Tel Aviv University. Her company, NLC Pharma, offers state of the art, close to the market technologies for very rapid, field operated detection of viruses that cause a pandemic threat (like Coronaviruses) and a companion diagnostics small molecule leads to combat these diseases.

T-Cell Protect is a complete multi-functional supplement, which is based on maintaining cell viability and is associated with fighting a variety of diseases and illnesses. As it seems to be related to the inhibition of excessive abnormal cell apoptosis, it is beneficial for the treatment of diseases such as those of cardiovascular, neurological in nature as well as auto-immune diseases.

The above benefits are supplementary to its anti-viral, anti-cancer and anti-inflammatory properties for which it plays a key role in the treatment of many viral infections, but also against COVID-19. It has an innovative design and a pharmacologically active mechanism of action and it does not simply support the immune system.

It is a 100% natural product, which should not be confused with other supplements on the market, as its efficacy is supported by clinical studies demonstrating the highest effectiveness and safety.

Lithospermum_erythrorhizon-1 Lithospermum Erythrorhizon pexels-nataliya-vaitkevich-7615574 1280px-Lithospermum_erythrorhizon Lithospermum Erythrorhizon The key ingredient of T-Cell Protect is Gromwell Root. Since ancient times, Gromwell Root extracts have been the key and well-known factors of Traditional Chinese Medicine as well as of Traditional Medicine of other Eastern countries in general.

They were used for burns, wounds, skin diseases and as an anti-inflammatory medicine. Many formulations of various components of this drug are now sold as dietary supplements and as herbal remedies against cancer. Shikonin is the active ingredient of Gromwell root and is one of the most famous active compounds of traditional use. Extensive studies conducted over the last 30 years have shown that Shikonin and its derivatives to be very important active ingredients for pharmacological uses.

Pharmaceutical facilities extensively studied Shikonin and the following conclusions have been derived:

Shikonin-containing extracts exhibit anti-inflammatory, anti-cancer and immunoregulatory properties in both the in vitro and the in vivo model systems. Shikonin has been shown to be extremely safe in a variety of pre-clinical studies having a strong safety history in common dietary supplements for human use. Shikonin is known for its anti-viral, anti-microbial and anti-cancer properties, while clinical trials on its anti-cancer properties continues to be performed. In fact, there is a patent established in 2005 on the anti-viral properties of Shikonin.

A test performed during the SARS epidemic showed that Shikonin reduced the course of SARS from 11 to 6 days and that it has anti-viral significant properties. Dr. Dorit Arad's team at eXegenics in 2001 found that Shikonin has molecular activity against several viruses, particularly the 3C-target viral protease enzyme, and it was detected as the most active compound among the 300,000 compounds studied in this study.

Gromwell Root, which contains 30% Shikonin, is regulated in Israel as a safe herbal supplement with a therapeutic index> 100 for concentrations up to 20mg per Kg. More about Shikonin’s antiviral properties:

When a virus infects the body's cells, it begins to use human cells and their various mechanisms in order to be able to reproduce and give new viruses. The process of activating cells to produce viral proteins and make more copies of the virus is a key point in the pathogenicity of the virus and its ability to infect new cells and survive.

Initially, the infected cell forms a series of viral proteins which are mostly non-functional. Some enzymes, called proteases, break down the precursor molecules of proteins in specific areas for the productive functional molecules that exist for viruses, survival, reproduction and the growth of new cells.

 COVID-19, like any other virus, is a single strand of RNA (or DNA) wrapped in a protein envelope.

The RNA contains the genetic instructions the virus needs to make copies of itself. Viruses spread with a simple two-step process:

I. Break into a healthy cell

II. Hijack the cell’s own mechanisms to make copies of itself Studies have shown, however, that by using protease inhibitors, we can stop the virus’ ability to replicate itself, thus, stopping it from spreading. To understand how this is done, let’s take a closer look at the lifecycle of a virus:

1. First, the virus must get inside the cell. Every virus does this slightly differently, but Coronaviruses (such as COVID-19) use their signature “spikes” to fuse themselves to a cell’s outer wall and then squeeze their way inside.

2. Once inside, the virus RNA converts into a polypeptide. This long protein is like a bus for the team of enzymes whose job it is to make more of the virus.

3. Before these enzymes can start working, they need to be separated from each other. The protease enzyme acts like a pair of scissors, cutting the polypeptide up into the different enzymes that then become functional.

4. When the protease enzyme comes in contact with a protease inhibitor, it is prevented from functioning. Protease inhibitor drugs are designed to tightly bind to the protease enzyme, blocking its ability to cleave.

This shuts down the entire virus-making apparatus, leaving it unable to make a single virus.